These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22494968)

  • 21. Efficacy and safety of recombinant human epidermal growth factor for diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials.
    Zhao DY; Su YN; Li YH; Yu TQ; Li J; Tu CQ
    Int Wound J; 2020 Aug; 17(4):1062-1073. PubMed ID: 32343054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
    Fernández-Montequín JI; Infante-Cristiá E; Valenzuela-Silva C; Franco-Pérez N; Savigne-Gutierrez W; Artaza-Sanz H; Morejón-Vega L; González-Benavides C; Eliseo-Musenden O; García-Iglesias E; Berlanga-Acosta J; Silva-Rodríguez R; Betancourt BY; López-Saura PA;
    Int Wound J; 2007 Dec; 4(4):333-43. PubMed ID: 17953679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers.
    Zimny S; Schatz H; Pfohl M
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):191-4. PubMed ID: 15127323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.
    Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A
    Am J Surg; 2007 Jan; 193(1):49-54. PubMed ID: 17188087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
    Browne AC; Vearncombe M; Sibbald RG
    Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.
    Fernández-Montequín JI; Betancourt BY; Leyva-Gonzalez G; Mola EL; Galán-Naranjo K; Ramírez-Navas M; Bermúdez-Rojas S; Rosales F; García-Iglesias E; Berlanga-Acosta J; Silva-Rodriguez R; Garcia-Siverio M; Martinez LH
    Int Wound J; 2009 Feb; 6(1):67-72. PubMed ID: 19291119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results.
    Tuyet HL; Nguyen Quynh TT; Vo Hoang Minh H; Thi Bich DN; Do Dinh T; Le Tan D; Van HL; Le Huy T; Doan Huu H; Tran Trong TN
    Int Wound J; 2009 Apr; 6(2):159-66. PubMed ID: 19432666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome.
    Berlanga-Acosta J; Fernández-Montequín J; Valdés-Pérez C; Savigne-Gutiérrez W; Mendoza-Marí Y; García-Ojalvo A; Falcón-Cama V; García Del Barco-Herrera D; Fernández-Mayola M; Pérez-Saad H; Pimentel-Vázquez E; Urquiza-Rodríguez A; Kulikovsky M; Guillén-Nieto G
    Biomed Res Int; 2017; 2017():2923759. PubMed ID: 28904951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal Growth Factor is Effective in the Treatment of Diabetic Foot Ulcers: Meta-Analysis and Systematic Review.
    Bui TQ; Bui QVP; Németh D; Hegyi P; Szakács Z; Rumbus Z; Tóth B; Emri G; Párniczky A; Sarlós P; Varga O
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31331038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomized controlled study of a Chinese herbal medicine compound Tangzu Yuyang Ointment for chronic diabetic foot ulcers: a preliminary report.
    Li S; Zhao J; Liu J; Xiang F; Lu D; Liu B; Xu J; Zhang H; Zhang Q; Li X; Yu R; Chen M; Wang X; Wang Y; Chen B
    J Ethnopharmacol; 2011 Jan; 133(2):543-50. PubMed ID: 21129474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.
    Brem H; Tomic-Canic M; Tarnovskaya A; Ehrlich HP; Baskin-Bey E; Gill K; Carasa M; Weinberger S; Entero H; Vladeck B
    Surg Technol Int; 2003; 11():161-7. PubMed ID: 12931298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers.
    Wainstein J; Feldbrin Z; Boaz M; Harman-Boehm I
    Diabetes Technol Ther; 2011 Dec; 13(12):1255-60. PubMed ID: 21751891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocol for treatment of diabetic foot ulcers.
    Brem H; Sheehan P; Boulton AJ
    Am J Surg; 2004 May; 187(5A):1S-10S. PubMed ID: 15147985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial.
    Mulder G; Tallis AJ; Marshall VT; Mozingo D; Phillips L; Pierce GF; Chandler LA; Sosnowski BK
    Wound Repair Regen; 2009; 17(6):772-9. PubMed ID: 19821960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.
    Grek CL; Prasad GM; Viswanathan V; Armstrong DG; Gourdie RG; Ghatnekar GS
    Wound Repair Regen; 2015; 23(2):203-12. PubMed ID: 25703647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot trial of biovance collagen-based wound covering for diabetic ulcers.
    Letendre S; LaPorta G; O'Donnell E; Dempsey J; Leonard K
    Adv Skin Wound Care; 2009 Apr; 22(4):161-6. PubMed ID: 19325275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of surgical debridement in healing of diabetic foot ulcers.
    Lebrun E; Tomic-Canic M; Kirsner RS
    Wound Repair Regen; 2010; 18(5):433-8. PubMed ID: 20840517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple-blind, placebo-controlled, clinical trial.
    Rullan M; Cerdà L; Frontera G; Masmiquel L; Llobera J
    Diabet Med; 2008 Sep; 25(9):1090-5. PubMed ID: 19183313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [System and regional antioxidan therapy by complicated diabetic foot].
    Beliaev AN; Rygin EA; Zakhvatov AN; Gulin AN; Gruznov AG
    Khirurgiia (Mosk); 2007; (11):46-50. PubMed ID: 18335589
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
    Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I
    Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.